FDA Clearance Tracker · P010059-S007
MORCHER Capsular Tension Ring, EYEJET CTR, MORCHER Injector
Last checked: Nov 20, 2026Latest source record: Sep 6, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 6, 2023
Approved
Time to decision
357 days
Received Sep 14, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010059-S007
- Device name
- MORCHER Capsular Tension Ring, EYEJET CTR, MORCHER Injector
- Applicant
- Morcher GmbH
- Applicant location
- Stuttgart
- Received
- Sep 14, 2022
- Decided
- Sep 6, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P010059
Device type
- Device type
- Ring, endocapsular (MRJ)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for expansion of the Capsular Tension Ring device family to include the new Type 20C Model.
Source documents
Other decisions for Morcher GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.